Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoglobin SE disease: a concise review.

David Masiello1, Matthew M Heeney, Adeboye H Adewoye

  • 1The Center of Excellence in Sickle Cell Disease, Department of Medicine, School of Medicine, Boston University, Boston, MA, USA.

American Journal of Hematology
|February 6, 2007
PubMed
Summary

Hemoglobin SE (Hb SE) disease is often mild in children but can cause serious complications in adults. Management should mirror that of Hb S/beta(+)-thalassemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026
Same author

Prevention, Screening, Diagnosis, and Treatment of Iron Deficiency and Iron Deficiency Anemia in Infants, Children, and Adolescents: Clinical Report.

Pediatrics·2026
Same author

Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.

The New England journal of medicine·2026
Same author

Modeling Genetic Diversity in Sickle Cell Disease Reveals Heterogeneous Responses to HbF-Inducing Therapies.

bioRxiv : the preprint server for biology·2026
Same author

PGC-1α agonism via oral administration of ZLN005 induces fetal hemoglobin and is antisickling in sickle mice.

Blood advances·2026
Same author

Base Editing of <i>HBG1</i> and <i>HBG2</i> Promoters for Sickle Cell Disease.

The New England journal of medicine·2026

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Hemoglobin SE (Hb SE) disease is a hemoglobinopathy.
  • It arises from compound heterozygosity for Hb S and Hb E.
  • This condition is increasingly recognized globally due to population migration.

Observation:

  • A case of an infant with Hb SE disease who was clinically well is presented.
  • Literature review indicates that individuals under 18 with Hb SE disease are typically asymptomatic.
  • Conversely, over 50% of patients aged 20 and older experience sickling-related complications.

Findings:

  • Hb SE disease patients exhibit 60-65% Hb S, comparable to Hb S/beta(+)-thalassemia.
  • Hematological parameters and clinical progression in Hb SE disease resemble those in Hb S/beta(+)-thalassemia.

Related Experiment Videos

  • Variable anemia and the potential for clinical complications are noted in Hb SE disease.

    • Implications:

    • Hb SE disease is expected to be diagnosed more frequently worldwide.
    • Management strategies for Hb SE disease should align with those for Hb S/beta(+)-thalassemia.
    • Prompt treatment of sickling-related symptoms and complications is crucial for patients with Hb SE disease.